Julia Kwaśna

Julia Kwaśna

Auto-generated profile, based on publicly available information

Julia Kwaśna

Medical University of Gdansk, Poland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2024 in European Neuropsychopharmacology
Verified
Journal Article
Closed access
AKAleksander Kwaśny
Aleksander Kwaśny
JKJulia Kwaśna
Julia Kwaśna
AWAlina Wilkowska
Alina Wilkowska
JSJoanna Szarmach
Joanna Szarmach
JSJakub Słupski
Jakub Słupski
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała

16 December 2024 in Quality in Sport
Verified
Journal Article
Open access
PDF file
IKIzabela Kaźmierczyk
Izabela Kaźmierczyk
MBMateusz Bychowski
Mateusz Bychowski
JKJulia Kwaśna
Julia Kwaśna
AZAdrianna Załęska
Adrianna Załęska
KLKacper Lenart
Kacper Lenart
JKJoanna Kulicka
Joanna Kulicka
Background: Passiflora incarnata (commonly known as passionflower) has a longstanding history in ethnopharmacology for its sedative and anxiolytic properties. Recent scientific advancements have expanded its applications, particularly in managing neuropsychiatric disorders such as anxiety, depression, and sleep disturbances. Objective: This review synthesizes current evidence regarding the pharmacological mechanisms, clinical applications, and safety profile of Passiflora incarnata in neuropsychiatric contexts. Methods: A systematic search of peer-reviewed literature from 2016 to 2024 was conducted to assess preclinical and clinical studies investigating the therapeutic potential of Passiflora incarnata. Results: The review identified significant evidence supporting its anxiolytic, sedative, and antidepressant properties, mediated through GABAergic modulation, serotonergic pathways, and other neurochemical mechanisms. Clinical trials demonstrated efficacy in managing perioperative anxiety, sleep disturbances, and benzodiazepine tapering. Its safety profile was favorable, with minimal adverse effects reported. Conclusion: Passiflora incarnata offers a promising herbal alternative or adjunct in the treatment of neuropsychiatric disorders, though further high-quality research is required to standardize its use.

25 November 2024 in The World Journal of Biological Psychiatry
Verified
Journal Article
Open access
JKJulia Kwaśna
Julia Kwaśna
AKAleksander Kwaśny
Aleksander Kwaśny
AWAlina Wilkowska
Alina Wilkowska
MBMateusz Bychowski
Mateusz Bychowski
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała
The primary objective in managing depression is achieving full recovery, but some patients experience ongoing symptoms that affect daily life, with residual hypersomnia being notably prevalent. Understanding its extent, frequency, and potential treatments is limited. This systematic review consolidates existing knowledge on the prevalence and treatment of residual hypersomnia in depression, drawing from PubMed, Web of Science, and Scopus databases. The protocol was registered in PROSPERO (CRD42023392062). Residual hypersomnia is highly prevalent in depression. Modafinil is the only pharmacological intervention studied, showing short-term effectiveness in randomised placebo-controlled trials. For patients with comorbid obstructive sleep apnoea (OSA), continuous positive airway pressure (CPAP) appears promising for reducing excessive sleepiness. Challenges arise from ambiguous definitions of 'residual symptoms', 'partial response', and 'hypersomnia', and the use of various scales to assess hypersomnia. The scarcity of placebo-controlled randomised trials complicates evaluating treatment efficacy and standardising management approaches. Given its high prevalence, managing residual hypersomnia is a significant challenge with current treatments appearing ineffective long-term. Data suggest benefits from modafinil augmentation and CPAP treatment, but more research is needed.

16 December 2024 in Quality in Sport
Verified
Journal Article
Open access
SBSzymon Bednarek
Szymon Bednarek
MGMateusz Górski
Mateusz Górski
AZAdrianna Załęska
Adrianna Załęska
MBMateusz Bychowski
Mateusz Bychowski
JKJulia Kwaśna
Julia Kwaśna
JKJoanna Kulicka
Joanna Kulicka
This study delves into the intricate connection between social media usage and mental health outcomes in adolescents. It aims to amalgamate results from various research studies to unveil trends and establish causal relationships concerning social media engagement, sleep quality, self-esteem, anxiety, and depression. A meta-analytic approach was utilized, consolidating information from 21 articles across diverse fields of psychology, public health, and adolescent behavior research. These studies investigated quantitative and qualitative facets of social media influence, emphasizing factors like general usage trends, nighttime-specific usage, and emotional engagement with social platforms. Standardized assessments of mental well-being, such as the Pittsburgh Sleep Quality Index (PSQI), the Hospital Anxiety and Depression Scale (HADS), and the Rosenberg Self-Esteem Scale (RSES), were scrutinized to maintain uniformity in the analysis. The primary outcomes suggest that extensive engagement with social media, especially at night, is closely tied to diminished sleep quality, heightened anxiety and depression, and reduced self-esteem. Emotional engagement on social platforms plays a crucial role in predicting adverse mental health effects, influenced by levels of anxiety and depression. Notably, using social media at night is consistently associated with disturbed sleep cycles, intensifying psychological anguish. This research emphasizes the crucial necessity for implementing specific interventions to regulate teenagers' social media engagement, especially at night. The results emphasize the significance of emotional involvement and habitual usage trends as pivotal subjects for future investigation and actionable measures to improve the well-being of adolescents. These observations are vital for guiding policy decisions, educational campaigns, and clinical approaches aimed at enhancing mental health outcomes in the era of digital technologies.

26 August 2024 in Pharmacological Reports
Verified
Journal Article
Open access
PDF file
JKJulia Kwaśna
Julia Kwaśna
WCWiesław Jerzy Cubała
Wiesław Jerzy Cubała
AKAleksander Kwaśny
Aleksander Kwaśny
AWAlina Wilkowska
Alina Wilkowska
Background: Emerging evidence indicates that intravenous ketamine is effective in managing treatment-resistant unipolar and bipolar depression. Clinical studies highlight its favorable efficacy, safety, and tolerability profile within a dosage range of 0.5-1.0 mg/kg based on actual body weight. However, data on alternative dosage calculation methods, particularly in relation to body mass index (BMI) and therapeutic outcomes, remain limited. Methods: This retrospective analysis of an open-label study aims to evaluate dose calculation strategies and their impact on treatment response among inpatients with treatment-resistant major depressive disorder (MDD) (n = 28). The study employed the Boer and Devine formulas to determine lean body mass (LBM) and ideal body weight (IBW), and the Mosteller formula to estimate body surface area (BSA). The calculated doses were then compared with the actual doses administered or converted to a dosage per square meter for both responders and non-responders. Results: Regardless of treatment response, defined as a reduction of 50% in the Montgomery-Åsberg Depression Rating Scale, the use of alternative ketamine dosing formulas resulted in underdosing compared to the standardized dose of 0.5 mg/kg. Only two participants received higher doses (102.7% and 113.0%) when the Devine formula was applied. Conclusions: This study suggests that ketamine dosing formulas, alternative to the standardized 0.5 mg/kg based on body weight, may lead to underdosing and potentially impact outcome interpretation. To enhance dosing accuracy, future studies should consider incorporating body impedance analysis and waist-to-hip ratio measurements, as this study did not account for body composition.

5 December 2024 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
MGMateusz Górski
Mateusz Górski
MBMateusz Bychowski
Mateusz Bychowski
JKJulia Kwaśna
Julia Kwaśna
AZAdrianna Załęska
Adrianna Załęska
IKIzabela Kaźmierczyk
Izabela Kaźmierczyk
JKJoanna Kulicka
Joanna Kulicka
Background: Air pollution poses a significant global health risk, affecting a wide range of conditions, including skin aging, atopic dermatitis, cardiovascular diseases, respiratory disorders, and cancer. Recent studies reveal its role in accelerating aging and exacerbating chronic conditions through mechanisms like oxidative stress and systemic inflammation. However, gaps remain in understanding pollutant-specific effects and their cumulative impact on health. Methods: This review synthesizes findings from recent studies examining the effects of air pollution on skin and systemic health. A comprehensive analysis was conducted across multiple health conditions, with a focus on pollutant-specific mechanisms, including oxidative stress, DNA damage, immune dysregulation, and inflammatory responses. Results: Findings highlight strong correlations between exposure to pollutants, such as PM2.5, SO2, NOx, and VOCs, with adverse health outcomes. Pollutants exacerbate conditions like wrinkles, atopic dermatitis, thrombosis, and lung cancer. Interestingly, some pollutants, like ozone, showed mixed effects on specific skin conditions, emphasizing the need for nuanced analysis. Conclusion: Understanding the multifaceted impact of air pollution underscores the urgent need for targeted interventions and policies to mitigate health risks. Further research is essential to develop precise strategies to address the pollutant-specific effects and protect vulnerable populations.